Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Tuesday, December 31, 2024.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2024 (2024-12-31): -655.11%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-447.34%
RETURN ON EQUITY (ROE) AVG 3Y
-236.17%
RETURN ON EQUITY (ROE) AVG 5Y
-202.95%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Celularity Inc.
Market Cap
$45.73M
Return on Equity (ROE)
N/A
TTM Avg
-447.34%
3Y Avg
-236.17%
5Y Avg
-202.95%
Market Cap
$47.27M
Return on Equity (ROE)
-28.20%
TTM Avg
-53.22%
3Y Avg
-59.23%
5Y Avg
-46.35%
Market Cap
$47.47M
Return on Equity (ROE)
-170.94%
TTM Avg
-132.56%
3Y Avg
-85.15%
5Y Avg
-88.00%
Market Cap
$44.97M
Return on Equity (ROE)
123.04%
TTM Avg
-60.38%
3Y Avg
-75.18%
5Y Avg
-82.51%
Market Cap
$44.96M
Return on Equity (ROE)
-212.45%
TTM Avg
-170.64%
3Y Avg
-104.70%
5Y Avg
-78.05%
Market Cap
$44.71M
Return on Equity (ROE)
513.56%
TTM Avg
488.17%
3Y Avg
265.30%
5Y Avg
226.12%
Market Cap
$48.53M
Return on Equity (ROE)
-23.70%
TTM Avg
-170.56%
3Y Avg
-190.10%
5Y Avg
-146.13%
Market Cap
$48.65M
Return on Equity (ROE)
-90.44%
TTM Avg
-163.19%
3Y Avg
-112.62%
5Y Avg
-86.58%
Market Cap
$48.99M
Return on Equity (ROE)
N/A
TTM Avg
-374.04%
3Y Avg
-326.22%
5Y Avg
-254.86%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celularity Inc. (CELU) | $45.73M | N/A | -447.34% | -236.17% | -202.95% |
| Instil Bio, Inc. (TIL)vs › | $47.27M | -28.20% | -53.22% | -59.23% | -46.35% |
| Lite Strategy, Inc. (LITS)vs › | $47.47M | -170.94% | -132.56% | -85.15% | -88.00% |
| DarioHealth Corp. (DRIO)vs › | $44.97M | 123.04% | -60.38% | -75.18% | -82.51% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.96M | -212.45% | -170.64% | -104.70% | -78.05% |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 513.56% | 488.17% | 265.30% | 226.12% |
| Microbot Medical Inc. (MBOT)vs › | $48.53M | -23.70% | -170.56% | -190.10% | -146.13% |
| INmune Bio, Inc. (INMB)vs › | $48.65M | -90.44% | -163.19% | -112.62% | -86.58% |
| TELA Bio, Inc. (TELA)vs › | $48.99M | N/A | -374.04% | -326.22% | -254.86% |
| Sensus Healthcare, Inc. (SRTS)vs › | $47.90M | -42.01% | -2.07% | 11.82% | 5.22% |
ROE
N/A
ROA
-71.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2024-12-31 | -655.11% |
| 2024-09-30 | -202.85% |
| 2024-06-30 | -405.70% |
| 2024-03-31 | -493.81% |
| 2023-12-31 | -479.24% |
| 2023-09-30 | -599.76% |
| 2023-06-30 | -69.82% |
| 2023-03-31 | 8.38% |
| 2022-12-31 | 7.14% |
| 2022-09-30 | -8.70% |
| 2022-06-30 | 20.55% |
| 2022-03-31 | -90.59% |
| 2021-12-31 | -100.70% |
| 2021-09-30 | -95.79% |
| 2020-06-30 | -66.42% |
| 2019-12-31 | -14.85% |
